Larson Pharma Private Limited

Larson Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24233TG2006PTC049977 Incorporated 20 April 2006 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹33.93 Cr
▲ 23% YoY
Net profit · FY 2025
₹79.01 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹2.61 Cr
EBITDA margin 7.7%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.45 Cr
Issued & subscribed
Open charges
₹13.64 Cr
Satisfied ₹5.7 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
21
Provident fund records

About Larson Pharma Private Limited

Data last updated:

Larson Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 April 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2006PTC049977. Its GSTIN is 29AAJCS8965Q1Z0 (Karnataka). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.45 Cr. It was formerly known as Larson Pharma Limited and Sasank Biotech Limited. It is led by directors Yeturu Sita Mahalakshmi and Yeturu Srinivasa Reddy.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.

As per the financials filed for FY 2025, the company reported a revenue of ₹33.93 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹79.01 Lakh (net margin 2.3%) and EBITDA of ₹2.61 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 26% over five years.

The company has about 21 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Larson Pharma. As per MCA filings, the company has open charges of ₹13.64 Cr and satisfied charges of ₹5.7 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022. Its 5 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Mancare Pharmaceuticals Private Limited with revenue of ₹34.15 Cr.

Larson Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-23-0000213). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website larsonpharma.in.

Company details

CIN U24233TG2006PTC049977
Registration Number 049977
Incorporation Date 20 April 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-23-0000213

Name history

Larson Pharma has undergone 2 name changes throughout its history. The company was previously known as Larson Pharma Limited, and Sasank Biotech Limited. The current legal name is Larson Pharma Private Limited.

Company NameStatus
Larson Pharma Private LimitedCurrent
Larson Pharma LimitedPrevious
Sasank Biotech LimitedPrevious

CIN history

Larson Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24233TG2006PTC049977, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233TG2006PTC049977Current
U24239AP2006PLC049977Previous
U24233TG2006PLC049977Previous
U24239TG2006PLC049977Previous

Recognitions & Rankings of Larson Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-KR-23-0000213

Contact details

Larson Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is larsonpharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049
  • Industry
    Pharma, API Manufacturers, Drug Formulation & Development

To see the full contact details of Larson Pharma Private Limited, buy the company report.

Comprehensive company report
Larson Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Larson Pharma operates one associated brand: Larson Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Specializes in manufacturing and supplying a range of pharmaceutical products and ingredients.larsonpharma.in

Business activity

The main business activity of Larson Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Larson Pharma Private Limited, buy the company report.

Financials of Larson Pharma Private Limited

FY 2025 filings available

Larson Pharma Private Limited reported revenue of ₹33.93 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹33.93 Cr ▲ 23%
Net profit · FY 2025
₹79.01 Lakh margin 2.3%
EBITDA · FY 2025
₹2.61 Cr margin 7.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 3%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 29%
5 years · compounded
▲ 15%

Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 23% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.61 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹79.01 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.7%
Net Profit Margin2.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Larson Pharma Private Limited, buy the company report.

Board of directors of Larson Pharma Private Limited

Larson Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Yeturu Sita MahalakshmiDirector20 Dec 201114 Years 10 MonthsCurrent
Yeturu Srinivasa ReddyDirector20 Apr 200620 Years 6 MonthsCurrent

Peer comparison

Larson Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mancare Pharmaceuticals Private Limited₹34.15 Cr (FY 2025)-1.0%Vasai, Maharashtra, India
Maps Laboratories Private Limited₹34.03 Cr (FY 2024)-25.0%Rajkot, Gujarat, India
Larson Pharma Private Limitedthis company₹33.93 Cr (FY 2025)₹79.01 Lakh2.3%23.0%21Hyderabad, Telangana, India
Supal Pharmacare Limited₹33.91 Cr (FY 2024)Ahmedabad, Gujarat, India
Vijaya Sai Laboratories India Private Limited₹33.9 Cr (FY 2025)-12.0%Telangana, India
Franco-Indian Remedies Private Limited₹33.65 Cr (FY 2024)-8.0%Tamil Nadu, India

To see the full peer comparison of Larson Pharma Private Limited, buy the company report.

Auditor

Larson Pharma Private Limited is audited by C V RAMANA & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
C V RAMANA & ASSOCIATESFY 2022009188S

Shareholding

The shareholding of Larson Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Larson Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹13.64 Cr
Satisfied charges
₹5.7 Cr
Breakdown by lending institutions
Axis Bank Limited₹11.65 Cr
Others₹1.71 Cr
Hdfc Bank Limited₹0.28 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Mar 2024100922525Others₹1.71 CrOpen
01 Jul 2022100594728Hdfc Bank Limited₹14.57 LakhOpen
12 May 2022100572354Axis Bank Limited₹11.65 CrOpen
18 Apr 2022100572119Hdfc Bank Limited₹13.58 LakhOpen
16 Jul 2021100461422Canara Bank₹1.95 CrSatisfied

To see the full charge records of Larson Pharma Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Larson Pharma Private Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022.

Total deals
4
Secondary share transfers
2
Rights issue
1
Funding round
1
Disclosed funding
₹2.71 Cr

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2016Rights issue₹3.69 CrInvestors: 3 individuals
Mar 2013Funding round₹2.71 CrInvestors: 4 individuals
Dec 2011Secondary share transferUndisclosedBuyer: 3 individuals
Seller: 3 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Larson Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Larson Pharma Private Limited has a workforce of 21 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
21
Active EPFO establishments
1
Employee growth
-16%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2721
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16

To see the full employee and EPFO history of Larson Pharma Private Limited, buy the company report.

GST

Larson Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
29AAJCS8965Q1Z0KarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Larson Pharma Private Limited, buy the company report.

Recent activity

Larson Pharma Private Limited has 5 board changes on record since 2006: 2 appointments and 3 cessations. The latest: Chandra Obulreddy Ramireddy ceased to be Director on 17 Mar 2021.

AGM
Larson Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 11.65 Cr registered on 12 May 2022 with Charge ID 100572354 was modified on 13 Jun 2025.
Filing
Larson Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 1.71 Cr with Charge ID 100922525 was registered on 30 Mar 2024.
Charges
A charge registered on 16 Jul 2021 via Charge ID 100461422 with Canara Bank was fully satisfied on 11 Aug 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100594728 was registered on 01 Jul 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 11.65 Cr with Charge ID 100572354 was registered on 12 May 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.14 Cr with Charge ID 100572119 was registered on 18 Apr 2022.
Charges
A charge with Canara Bank amounted to Rs. 1.95 Cr with Charge ID 100461422 was registered on 16 Jul 2021.
Ceased
Chandra Obulreddy Ramireddy ceased to be Director.
Charges
A charge registered on 28 Jul 2011 via Charge ID 10305805 with Canara Bank was fully satisfied on 26 Nov 2018.
Charges
A charge with Canara Bank of Rs. 3.75 Cr registered on 28 Jul 2011 with Charge ID 10305805 was modified on 26 Mar 2014.

6 earlier events are in the company report.

Frequently asked questions

Larson Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 April 2006 (20+ years old) and is registered under CIN U24233TG2006PTC049977.

Larson Pharma has 2 current directors:

The latest financial statements of Larson Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Larson Pharma is 29AAJCS8965Q1Z0, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Larson Pharma is U24233TG2006PTC049977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Larson Pharma has 1 court case on record: 1 filed by the company. 1 is pending.

Larson Pharma was incorporated on 20 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.

Larson Pharma has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022.

The peers of Larson Pharma by revenue are Mancare Pharmaceuticals Private Limited, Maps Laboratories Private Limited, Supal Pharmacare Limited, Vijaya Sai Laboratories India Private Limited, Franco-Indian Remedies Private Limited, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Chandra Obulreddy Ramireddy ceased to be Director on 17 Mar 2021. Yeturu Sita Mahalakshmi ceased to be Additional Director on 29 Sep 2012. Gangi Reddy Narravula ceased to be Director on 20 Dec 2011. Larson Pharma has 5 board changes on record in total.

Yes, Larson Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-23-0000213).